ENTITY
Kolon TissueGene

Kolon TissueGene (950160 KS)

16
Analysis
Health Care • United States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
•19 Feb 2018 10:27

Korean IPOs - Evidence-Based Analysis & The Whiplash Effect

In this report, we provide evidence-based analysis of using key criteria such as the IPO price determined at high/low end of the IPO price range...

Logo
370 Views
Share
•25 Nov 2017 21:53

Summary of KOSDAQ 150 December Reshuffle & Rebalancing

It was officially announced that a total of 13 stocks would be newly added to KOSDAQ 150 in the upcoming periodical reshuffle, whereas the same...

Logo
746 Views
Share
•16 Nov 2017 22:57

KOSDAQ's Bullish Run - Main Drivers & Stocks to Pick

KOSDAQ is getting really hot. Over the past three months, KOSDAQ index climbed 22.89% by 145.31 points from 642.11 on Aug 17 to 780.22 today on Nov...

Logo
799 Views
Share
•13 Aug 2025 07:05

KRX Short Interest Weekly (Aug 8th): Silicon2, NAVER, LG Chem, KakaoBank, POSCO FUTURE M

We analyzed KRX short interest report for the past week and highlighted short interest changes in Silicon2, NAVER, LG Chem, KakaoBank, POSCO FUTURE M.

Logo
367 Views
Share
•11 Aug 2025 12:06

Kolon Mobility (450140 KS)'s Delisting Offer

Trading tight to the cash terms at a 0.7%/9.8% and 0.7%/8.6% gross/annual spread for the common & preferred. The scrip terms for both are well out...

Logo
363 Views
Share
x